Compare AFYA & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AFYA | AZTA |
|---|---|---|
| Founded | 1999 | 1978 |
| Country | Brazil | United States |
| Employees | 9395 | N/A |
| Industry | Other Consumer Services | Industrial Machinery/Components |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2019 | 1996 |
| Metric | AFYA | AZTA |
|---|---|---|
| Price | $14.51 | $25.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $17.00 | ★ $40.60 |
| AVG Volume (30 Days) | 125.4K | ★ 658.5K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | N/A | ★ 60.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | $10.43 | $6.99 |
| Revenue Next Year | $7.15 | $5.98 |
| P/E Ratio | $9.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.00 | $15.93 |
| 52 Week High | $16.47 | $41.73 |
| Indicator | AFYA | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 59.70 |
| Support Level | $14.24 | $21.88 |
| Resistance Level | $14.77 | $27.37 |
| Average True Range (ATR) | 0.42 | 1.15 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 29.14 | 65.51 |
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.